Literature DB >> 20860727

Conjunctival melanoma: local-regional control rates, and impact of high-risk histopathologic features.

Aaron Savar1, Bita Esmaeli, Hao Ho, Suyu Liu, Victor G Prieto.   

Abstract

BACKGROUND: Conjunctival melanoma is an uncommon malignancy with the potential for significant morbidity. Ulceration is known to be an indicator of more aggressive cutaneous melanoma. This factor has not been previously evaluated in conjunctival melanoma.
METHODS: Twenty-six patients with conjunctival melanoma who underwent excision by a single surgeon at a cancer referral center treated between June 2003 and July 2008 were included. The medical records were reviewed for clinical and pathological data. Outcomes assessed included local recurrence, regional lymph node metastasis, distant metastasis, use of adjuvant topical chemotherapy or adjuvant radiation therapy, final visual acuity and death.
RESULTS: Local recurrence was seen in three patients (12%). Regional lymph node metastasis and distant metastasis were each seen in four patients (15%). Tumors >2.0 mm thick were more likely to develop distant metastasis than those with a thickness of <2.0 mm (p = 0.0331). Ulceration was noted in 10 of 26 patients. Regional lymph node metastasis and distant metastasis were each seen in 4 of 10 patients with ulceration, and none of the patients without ulceration.
CONCLUSIONS: Ulceration in conjunctival melanoma may be an important histopathologic predictor of a more aggressive tumor. Globe-sparing multi-modality management of conjunctival melanoma can yield acceptable rates of local-regional recurrence.
Copyright © 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2010        PMID: 20860727     DOI: 10.1111/j.1600-0560.2010.01625.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  11 in total

Review 1.  Advances in the management of conjunctival melanoma.

Authors:  Gargi K Vora; Hakan Demirci; Brian Marr; Prithvi Mruthyunjaya
Journal:  Surv Ophthalmol       Date:  2016-06-16       Impact factor: 6.048

2.  Conjunctival melanoma: association of cyclooxygenase-2 tumor expression to prognosis.

Authors:  Rita Pinto-Proença; Mariana Santos; Cristina Fonseca; Júlia Fernandes; Maria Filomena Gaspar; Rui Proença
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-02       Impact factor: 3.117

Review 3.  Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence?

Authors:  Pia R Mendoza; Hans E Grossniklaus
Journal:  Int Ophthalmol Clin       Date:  2015

4.  Management of Conjunctival Melanoma: Critical Assessment of Sentinel Lymph Node Biopsy.

Authors:  Hassan A Aziz; Brian R Gastman; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2015-05-06

5.  Ocular melanoma.

Authors:  Bertil E Damato; Sarah E Coupland
Journal:  Saudi J Ophthalmol       Date:  2012-04

6.  Conjunctival malignant melanoma: A rare variant and review of important diagnostic and therapeutic considerations.

Authors:  Danah H Albreiki; Steven M Gilberg; James P Farmer
Journal:  Saudi J Ophthalmol       Date:  2012-04

7.  Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis).

Authors:  Bita Esmaeli; Dianna Roberts; Merrick Ross; Melissa Fellman; Hilda Cruz; Stella K Kim; Victor G Prieto
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12

8.  Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma.

Authors:  Bennett Yau-Bun Hong; Joshua R Ford; Isabella C Glitza; Carlos A Torres Cabala; Michael Tetzlaff; Victor G Prieto; Richard Parker; Claire Daniel; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021 Jan-Feb 01       Impact factor: 2.011

9.  Conjunctival Melanoma Angiotropic Microsatellitosis: A Mechanism of Local Extravascular Migratory Metastasis.

Authors:  Jose J Echegaray; Gabrielle Yeaney; Rachel Chen; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2020-01-21

10.  Oncologic and visual outcomes after postoperative proton therapy of localized conjunctival melanomas.

Authors:  Juliette Thariat; Julia Salleron; Celia Maschi; Edouard Fevrier; Sandra Lassalle; Lauris Gastaud; Stephanie Baillif; Audrey Claren; Florent Baumard; Joel Herault; Jean Pierre Caujolle
Journal:  Radiat Oncol       Date:  2019-12-27       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.